Pharmaceutical Biotechnology: Fundamentals and Applications
- Lecture Notes, Study Materials and Important questions answers
Subject : Pharmaceutical Biotechnology: Fundamentals and Applications
Molecular Biotechnology
- Molecular Biotechnology: Introduction - Answer (click here)
- The Cells: Prokaryotic Cell and Eukaryotic Cell - Answer (click here)
- Gene Expression - Answer (click here)
- DNA Replication - Answer (click here)
- Gene Transcription - Answer (click here)
- Gene Translation - Answer (click here)
- Recombinant DNA Technology - Answer (click here)
- DNA Transfer - Recombinant DNA Technology - Answer (click here)
- DNA Sources - Recombinant DNA Technology - Answer (click here)
- Production by Recombinant DNA Technology - Answer (click here)
- DNA Sequencing - Answer (click here)
- Genome Sequencing - Answer (click here)
- DNA Hybridization - Answer (click here)
- PCR Technology - Answer (click here)
- Cell Cultures: Cultivation of Microbes, Animal and Plant Cell Cultures - Answer (click here)
Biophysical and Biochemical Analysis of Recombinant Proteins
- Biophysical and Biochemical Analysis of Recombinant Proteins - Answer (click here)
- Protein Structure: Primary Structure - Answer (click here)
- Protein Structure: Secondary Structure - Answer (click here)
- Protein Structure: Tertiary Structure - Answer (click here)
- Protein Structure: Forces - Answer (click here)
- Protein Structure: Hydration - Answer (click here)
- Protein Folding - Answer (click here)
- Protein Stability - Answer (click here)
- Blotting Techniques - Proteins Analytical Techniques - Answer (click here)
- Immunoassays ELISA - Proteins Analytical Techniques - Answer (click here)
- Electrophoresis - Proteins Analytical Techniques - Answer (click here)
- Chromatography - Proteins Analytical Techniques - Answer (click here)
- Bioassays - Proteins Analytical Techniques - Answer (click here)
- Mass Spectrometry - Proteins Analytical Techniques - Answer (click here)
Production and Downstream Processing of Biotech Compounds
- Production and Downstream Processing of Biotech Compounds - Answer (click here)
- Expression Systems - Production of Biotech Compounds - Answer (click here)
- Cultivation Systems - Production of Biotech Compounds - Answer (click here)
- Cultivation Medium - Production of Biotech Compounds - Answer (click here)
- Contaminants - Production of Biotech Compounds - Answer (click here)
- Cellular DNA - Production of Biotech Compounds - Answer (click here)
- Downstream Processing of Biotech Compounds - Answer (click here)
- Filtration/Centrifugation - Downstream Processing of Biotech Compounds - Answer (click here)
- Precipitation - Downstream Processing of Biotech Compounds - Answer (click here)
- Chromatography - Downstream Processing of Biotech Compounds - Answer (click here)
- Issues to Consider in Production And purification of Proteins - Answer (click here)
Formulation of Biotech Products Including Biopharmaceutical Considerations
- Microbiological Considerations - Answer (click here)
- Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Solubility Enhancers - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Anti Adsorption and Anti Aggregation Agents - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Buffer Components - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Preservatives and Antioxidants - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Osmotic Agents - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Shelf Life of Protein Based Pharmaceuticals - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Freeze Drying of Proteins - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Freezing - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Primary Drying - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Secondary Drying - Excipients Used in Parenteral Formulations of biotech Products - Answer (click here)
- Delivery of Proteins: Routes of Administration and Absorption Enhancement - Answer (click here)
- Delivery of Proteins: By The Parenteral Route - Answer (click here)
- Delivery of Proteins: Approaches For Rate Controlled Delivery - Answer (click here)
- Delivery of Proteins: Site Specific Delivery (Targeting) of Protein Drugs - Answer (click here)
- Anatomical, Physiological, and Pathological Considerations Relevant for Protein Targeting - Answer (click here)
- Soluble Carrier Systems for Targeted Delivery of Proteins - Answer (click here)
- Potential Pitfalls in Tumor Targeting - Answer (click here)
- Colloidal Particulate Carrier Systems for TargetedDelivery of Proteins: Nanotechnology at Work - Answer (click here)
- Perspectives for Targeted Protein Delivery - Answer (click here)
Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs
- Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs - Answer (click here)
- Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Absorption of Protein Therapeutics - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Distribution of Protein Therapeutics - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Elimination of Protein Therapeutics - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Target Mediated Drug Disposition - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Immunogenicity and Protein Pharmacokinetics - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Species Specificity and Allometric Scaling - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Chemical Modifications for Optimizing the Pharmacokinetics of Protein Therapeutics - Pharmacokinetics of Protein Therapeutics - Answer (click here)
- Pharmacodynamics of Protein Therapeutics - Answer (click here)
- Direct Link PK/PD Models - Pharmacodynamics of Protein Therapeutics - Answer (click here)
- Indirect Link PK/PD Models - Pharmacodynamics of Protein Therapeutics - Answer (click here)
- Indirect Response PK/PD Models - Pharmacodynamics of Protein Therapeutics - Answer (click here)
- Cell Life Span Models - Pharmacodynamics of Protein Therapeutics - Answer (click here)
- Complex Response Models - Pharmacodynamics of Protein Therapeutics - Answer (click here)
Immunogenicity of Therapeutic Proteins
- Immunogenicity of Therapeutic Proteins - Answer (click here)
- The New Paradigm - Answer (click here)
- The Immunological Response - Answer (click here)
- Factors Influencing Antibody Formation Totherapeutic Proteins - Answer (click here)
- Assays for Antibodies - Answer (click here)
- Issues Specifically Related Tomonoclonal Antibodies - Answer (click here)
- Clinical Effects of Induced Antibodies - Answer (click here)
- Predicting and Reducing Immunogenicity - Answer (click here)
Genomics Other Omics Technologies Personalized Medicine and Additional Biotechnology Related Techniques
- Genomics, “Omics” Technologies, Personalized Medicine - Answer (click here)
- An Introduction to “Omics” Technologies - Answer (click here)
- Genomics - An Introduction to “Omics” Technologies - Answer (click here)
- “Omics” Enabling Technology: Bioinformatics - Answer (click here)
- Transcriptomics - An Introduction to “Omics” Technologies - Answer (click here)
- Proteomics, Structural Proteomics, and Functional Proteomics - “Omics” Technologies - Answer (click here)
- “Omics” Enabling Technology: Microarrays - Answer (click here)
- “Omics” Enabled Technology: BriefIntroduction to Biomarkers - Answer (click here)
- Metabonomics and Metabolomics - Answer (click here)
- Pharmacogenetics and Pharmacogenomics - Answer (click here)
- Toxicogenomics - Answer (click here)
- Glycomics and Glycobiology - Answer (click here)
- “Omics” Integrating Technology: Systems Biology - Answer (click here)
- Transgenic Animals - Answer (click here)
- Transgenic Plants - Answer (click here)
- Xenotransplantation: Transplantable Transgenic Animal Organs - Answer (click here)
- Knockout Mice - Answer (click here)
- Protein Engineering - Answer (click here)
- 3D Structures of Engineered Proteins - Answer (click here)
- Peptide Chemistry and Peptidomimetics - Answer (click here)
- Cell Therapy and Regenerative Medicine - Answer (click here)
- Stem Cells - Cell Therapy and Regenerative Medicine - Answer (click here)
- Tissue Engineering and Some Products of Tissue Engineering - Cell Therapy and Regenerative Medicine - Answer (click here)
- Biotechnology and Drug Discovery - Answer (click here)
- Screening and Synthesis - Biotechnology and Drug Discovery - Answer (click here)
- Chemical Genomics - Biotechnology and Drug Discovery - Answer (click here)
Gene Therapy
- Gene Therapy - Answer (click here)
- Ex Vivo Versus In Vivo Gene Therapy - Answer (click here)
- Gene Therapy in The Clinic: Disease Targets - Answer (click here)
- General Considerations - Vectors For Gene Transfer - Answer (click here)
- General Anatomy and Production of a Gene Transfer Vector - Answer (click here)
- Retroviral Vectors - Viral Vectors for Gene Transfer - Answer (click here)
- Adenoviral Vectors - Viral Vectors for Gene Transfer - Answer (click here)
- Adeno Associated Virus Vectors - Viral Vectors for Gene Transfer - Answer (click here)
- Non-Viral Vectors for Gene Transfer - Answer (click here)
- Construction of Non Viral Vectors - Answer (click here)
- Delivery Methods for Non-Viral Gene Transfer - Answer (click here)
- The Immune Response Against Non-Viral Vectors - Answer (click here)
- Clinical Use of Non-Viral Vectors - Answer (click here)
- Production and Processing of Non-Viral Vectors - Answer (click here)
- The Role of Drug Metabolism in Gene Therapy - Answer (click here)
- Gene Directed Enzyme Prodrug Therapy (GDEPT) - Answer (click here)
- Systems for Pharmacological Regulation of Gene Expression - Answer (click here)
- Regulation and Oversight of Gene Therapy Products - Answer (click here)
Oligonucleotides
- Oligonucleotides - Answer (click here)
- Interfering With Gene Expression - Oligonucleotides - Answer (click here)
- Triple Helix-Forming Oligonucleotides - Answer (click here)
- Transcription Factor Decoys - Oligonucleotides Interfering With Gene Expression - Answer (click here)
- Antisense/Ribozymes/EGS - Oligonucleotides Interfering With Gene Expression - Answer (click here)
- siRNA/miRNA - Oligonucleotides Interfering With Gene Expression - Answer (click here)
- Direct Binding to Non-Nucleic Acids - Answer (click here)
- Gene Repair - Answer (click here)
- Stimulating Immune Responses - Answer (click here)
- Pharmacokinetics of Oligonucleotide-Based Therapeutics - Answer (click here)
- Improving Oligonucleotide Stability - Answer (click here)
- Improving Cellular Uptake - Answer (click here)
- Diagnostic Applications - Answer (click here)
Hematopoietic Growth Factors
- Hematopoietic Growth Factors - Answer (click here)
- Hematopoiesis - Answer (click here)
- Chemical Description of Hematopoietic Growth Factors - Answer (click here)
- Chemical Properties and Marketing Information for the Myeloid Factors, G-CSF and GM-CSF - Answer (click here)
- Chemical Properties and Marketing Information for SCF - Answer (click here)
- Chemical Properties and Marketing Information for TPOs - Answer (click here)
- Pharmacology - Answer (click here)
- Pharmaceutical Issues - Answer (click here)
- Pharmacokinetics - Answer (click here)
- Pharmacodynamics - Answer (click here)
- Established Uses - Hematopoietic Growth Factors - Answer (click here)
- AIDS - Pharmaceutical Biotechnology - Answer (click here)
- Toxicities - Answer (click here)
Interferons and Interleukins
- Interferons and Interleukins - Answer (click here)
- Interferons: Nomenclature and Functions - Answer (click here)
- Interleukins: Nomenclature and Functions - Answer (click here)
- Rapeutic Use of Recombinant Interferons - Answer (click here)
- Therapeutic Use of Recombinant Interleukins - Answer (click here)
- Aldesleukin - Therapeutic Use of Recombinant Interleukins - Answer (click here)
- Oprelvekin - Therapeutic Use of Recombinant Interleukins - Answer (click here)
- Anakinra - Therapeutic Use of Recombinant Interleukins - Answer (click here)
- Pegylated Interferons and Interleukins: The Next Generation - Answer (click here)
Insulin
- Insulin - Answer (click here)
- Chemical Description of Insulin - Answer (click here)
- Pharmacology and Formulations of Insulin - Answer (click here)
- Regular and Rapid Acting Soluble Formulations - Pharmacology and Formulations of Insulin - Answer (click here)
- Intermediate Acting Insulin Formulations - Pharmacology and Formulations of Insulin - Answer (click here)
- Long Acting Insulin Formulations - Pharmacology and Formulations of Insulin - Answer (click here)
- Chemical Stability of Insulin Formulations - Answer (click here)
- Physical Stability of Insulin Formulations - Answer (click here)
- Clinical and Practice Aspects of Insulin - Answer (click here)
Growth Hormones
- Human growth hormone (hGH): Structure and Isohormones - Answer (click here)
- Growth Hormone Secretion and Regulation - Answer (click here)
- Growth Hormone Biologic Actions - Answer (click here)
- hGH Receptor and Binding Proteins - Answer (click here)
- Molecular Endocrinology and Signal Transduction - Answer (click here)
- Dosing Schedules and Routes of Human growth hormone (hGH) - Answer (click here)
- Pharmacokinetics and Metabolism - Answer (click here)
- Protein Manufacture, Formulation and Stability- Growth Hormones - Answer (click here)
- Clinical Usage of Human growth hormone (hGH) - Answer (click here)
Recombinant Coagulation Factors and Thrombolytic Agents
- Recombinant Coagulation Factors and Thrombolytic Agents - Answer (click here)
- Recombinant Coagulation Factors VIII - Answer (click here)
- Recombinant Coagulation Factor VIIA - Answer (click here)
- Recombinant Coagulation Factor IX - Answer (click here)
- Tissue Type Plasminogen Activator - Recombinant Thrombolytic Agents - Answer (click here)
- Recombinant t-PA (rt-PA; Alteplase) - First Generation Recombinant Thrombolytic Agents - Answer (click here)
- Second Generation Recombinant Thrombolytic Agents - Answer (click here)
- Reteplase - Second Generation Recombinant Thrombolytic Agents - Answer (click here)
- Tenecteplase - Thrombolytic Agents - Answer (click here)
- Lanoteplase - Thrombolytic Agents - Answer (click here)
Monoclonal Antibodies From Structure to Therapeutic Application
- Monoclonal Antibodies: From Structure to Therapeutic Application - Answer (click here)
- Antibody Structure and Classes - Answer (click here)
- Murine, Chimeric, Humanized and Fully Humanized mAbs - Antibody Structure and Classes - Answer (click here)
- Antibody Derivatives [F(ab0)2, Fab, Antibody DrugConjugates (ADC)] and Fusion Proteins - Answer (click here)
- How Antibodies Function as Therapeutics - Answer (click here)
- Translational Medicine/Development Process - Answer (click here)
- Preclinical Safety Assessment of mAbs - Translational Medicine/Development Process - Answer (click here)
- Pharmacokinetics - Translational Medicine/Development Process - Answer (click here)
- Prediction of Human PK/PD Based on Preclinical Information - Answer (click here)
- PK/PD in Clinical Development of Antibody Therapeutics - Answer (click here)
- Mechanistic Modeling Approaches - Translational Medicine/Development Process - Answer (click here)
- Population PK of Monoclonal Antibodies - Answer (click here)
Monoclonal Antibodies in Cancer
- Monoclonal Antibodies in Cancer - Answer (click here)
- Alemtuzumab - Classes of Monoclonal Antibodies: CD Antigens - Answer (click here)
- Gemtuzumab - Monoclonal Antibodies in Cancer - Answer (click here)
- Rituximab, Yttrium-90 (90Y) Ibritumomab Tiuxetan, Iodine-131 (131I) Tositumomab - Answer (click here)
- Bevacizumab - Classes of Monoclonal Antibodies: Vascular Endothelial Growth Factor Inhibitors - Answer (click here)
- Trastuzumab - Classes of Monoclonal Antibodies: Endothelial Growth Factor Receptor (EGFR) Inhibitors - Answer (click here)
- Cetuximab - Classes of Monoclonal Antibodies: Endothelial Growth Factor Receptor (EGFR) Inhibitors - Answer (click here)
- Panitumumab - Classes of Monoclonal Antibodies: Endothelial Growth Factor Receptor (EGFR) Inhibitors - Answer (click here)
Monoclonal Antibodies in Solid Organ Transplantation
- Monoclonal Antibodies in Solid Organ Transplantation - Answer (click here)
- Immunologic Targets: Rational Development/ Use of Monoclonal Antibodies in Organ Transplant - Answer (click here)
- Monoclonal Antibodies Administered Pre-Transplant - Answer (click here)
- Monoclonal Antibodies Administered at the Time of Transplant - Answer (click here)
- Monoclonal Antibodies Administered Following Transplant - Answer (click here)
- Muromonab - Specific Agents Used In Solid Organ Transplant - Answer (click here)
- Interleukin 2 Receptor Antagonists - Specific Agents Used In Solid Organ Transplant - Answer (click here)
- Alemtuzumab - Specific Agents Used In Solid Organ Transplant - Answer (click here)
- Rituximab - Specific Agents Used In Solid Organ Transplant - Answer (click here)
Monoclonal Antibodies in Anti inflammatory Therapy
- Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Infliximab - Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Etanercept - Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Adalimumab - Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Abatacept - Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Rituximab - Arthritides - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Psoriasis: Efalizumab - Monoclonal Antibodies - Answer (click here)
- Multiple Sclerosis: Natalizumab - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
- Allergic Asthma: Omalizumab - Monoclonal Antibodies in Anti inflammatory Therapy - Answer (click here)
Recombinant Human Deoxyribonuclease I
- Recombinant Human Deoxyribonuclease I - Answer (click here)
- Protein Chemistry, Enzymology, and Structure - Answer (click here)
- In Vitro Activity in CF Sputum - Pharmacology - Recombinant Human Deoxyribonuclease I - Answer (click here)
- In Vivo Activity in CF Sputum - Pharmacology - Recombinant Human Deoxyribonuclease I - Answer (click here)
- Pharmacokinetics and Metabolism - Pharmacology - Recombinant Human Deoxyribonuclease I - Answer (click here)
- Protein Manufacturing and Formulation - Answer (click here)
- Drug Delivery- Recombinant Human Deoxyribonuclease I - Answer (click here)
- Clinical Use- Recombinant Human Deoxyribonuclease I - Answer (click here)
Follicle
- Follicle Stimulating Hormone - Answer (click here)
- Biological Role of Follicle Stimulating Hormone - Answer (click here)
- Chemical Description of Follicle Stimulating Hormone - Answer (click here)
- Production of Recombinant FSH(Follicle Stimulating Hormone) - Answer (click here)
- Structural Characteristics of Isohormones - Follicle Stimulating Hormone - Answer (click here)
- Biological Properties of Recombinant FSH Isohormones - Answer (click here)
- Pharmacokinetic Behavior of Recombinant FSH Isohormones - Answer (click here)
- Pharmaceutical Formulations of Follicle Stimulating Hormone(FSH) - Answer (click here)
- Clinical Aspects of Follicle Stimulating Hormone(FSH) - Answer (click here)
Vaccines
- Vaccines - Answer (click here)
- Immunological Principles of Vaccines - Answer (click here)
- Active Immunization: Generation of an Immune Response - Answer (click here)
- Uptake - Immunological Principles of Vaccines - Answer (click here)
- Activation and Migration - Immunological Principles of Vaccines - Answer (click here)
- Antigen Presentation and Lymphocyte Activation - Answer (click here)
- Adaptive Immune System - Immunological Principles of Vaccines - Answer (click here)
- Vaccine Design in Relation with the Immune Response - Answer (click here)
- Route of Administration - Immunological Principles of Vaccines - Answer (click here)
- Conventional Vaccines: Classification - Answer (click here)
- Live Attenuated Vaccines - Answer (click here)
- Non-Living Vaccines: Whole Organisms, Subunit Vaccines - Answer (click here)
- Genetically Improved Live Vaccines - Answer (click here)
- Genetically Improved Subunit Vaccines - Answer (click here)
- Reverse Vaccinology - Answer (click here)
- Therapeutic Vaccines - Answer (click here)
- Pharmaceutical Aspects of Vaccines - Answer (click here)
Dispensing Biotechnology Products Handling Professional Education and Product Information
- Dispensing Biotechnology Products: Handling, Professional Education, and Product Information - Answer (click here)
- Pharmacist Reluctance - Answer (click here)
- Types of Information Needed by Pharmacists - Pharmacist Reluctance - Answer (click here)
- Sources of Information for Pharmacists - Answer (click here)
- The Pharmacist and Handling of Biotech Drugs - Answer (click here)
- Temperature Requirements - Pharmacist Reluctance - Answer (click here)
- Storage in Dosing and Administration Devices - Pharmacist Reluctance - Answer (click here)
- Storage in IV Solutions and Light Protection - Pharmacist Reluctance - Answer (click here)
- Mixing and Shaking - Pharmacist Reluctance - Answer (click here)
- Travel Requirements - Pharmacist Reluctance - Answer (click here)
- Preparation of Biotechnology Products - Answer (click here)
- Administration of Biotechnology Products - Answer (click here)
- Biogenerics - A Future Consideration? - Answer (click here)
- Outpatient/Home Care Issues of Biotechnology Products - Answer (click here)
Economic Considerations in Medical Biotechnology
- Economic Considerations in Medical Biotechnology - Answer (click here)
- The Value of a New Medical Technology - Answer (click here)
- An Overview of Economic Analysis for New Technologies - Answer (click here)
No comments:
Post a Comment